novo glp 1 GLP-1s for Alzheimer's: Nordisk announces trial conclusion GLP-1 Drug Fails to Quell
Description
However, these changes were minor and not clinically significant, meaning no dose adjustments are necessary for these drugs when used alongside GLP-1RAs
Read more here: To view or add a comment, sign in More from this author Explore related topics Explore content categories
All samples were serially diluted in assay buffer in duplicate and incubated with the cells for 30 min at room temperature (RT) before detection with the cAMP dynamic 2 HTRF assay as described previously 72
However, it is very important to use these products safely
